Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 113 clinical trials
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis

changes over time in Idiopathic Pulmonary Fibrosis (IPF) patients receiving approved IPF treatments. Subjects will undergo an approximately hour long comprehensive MRI protocol, including

dyspnea
ct scan
pulmonary function test
idiopathic pulmonary fibrosis
nintedanib
  • 4 views
  • 18 May, 2022
  • 1 location
Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis

Pulmonary rehabilitation should be initiated and lifelong at the time of diagnosis for patients with IPF. However, the symptoms of the disease and its progression limit clinical options in terms of participation and sustainability in rehabilitation programs. For this purpose, patients with IPF need physiotherapy and rehabilitation options that will …

idiopathic pulmonary fibrosis
interstitial lung disease
pulmonary disease
pulmonary rehabilitation
  • 134 views
  • 13 Mar, 2022
  • 1 location
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis (STOP-IPF)

cause (idiopathic pulmonary fibrosis or IPF), neither drug is curative, and nearly 40% of patients stop taking the prescribed drug within a year because of side effects. The study includes the use of

bronchodilator
tubal ligation
follicle stimulating hormone
hysterectomy
scarring
  • 0 views
  • 24 Apr, 2022
  • 4 locations
Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis (HALT-IPF)

pulmonary fibrosis. Participants Patients with Idiopathic Pulmonary Fibrosis (IPF) Procedures (methods): 24 patients previously diagnosed with idiopathic

lung biopsy
idiopathic pulmonary fibrosis
walk tests
forced vital capacity
ct scan
  • 4 views
  • 15 May, 2022
  • 1 location
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis (GKT137831)

A placebo-controlled, multicenter, randomized trial to test GKT137831 in ambulatory patients with idiopathic pulmonary fibrosis. This drug is an inhibitor of nicotinamide adenine dinucleotide

idiopathic pulmonary fibrosis
forced vital capacity
pulmonary disease
  • 26 views
  • 02 May, 2022
  • 1 location
Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).

Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease marked by reduced exercise capacity and activity-related breathlessness (commonly termed dyspnea). Our previous work has shown

dyspnea
interstitial lung disease
Accepts healthy volunteers
idiopathic pulmonary fibrosis
cardiopulmonary exercise testing
  • 0 views
  • 06 May, 2022
  • 1 location
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

tomography (PET/CT) will show lung inflammation and fibrosis in patients diagnosed with idiopathic pulmonary fibrosis (IPF). This study may help physicians and researchers better understand how best to treat

forced vital capacity
positron emission tomography
idiopathic pulmonary fibrosis
  • 0 views
  • 20 Jun, 2022
  • 1 location
Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE-IPF)

Acute exacerbations (AE) are a dreaded manifestation of idiopathic pulmonary fibrosis (IPF) that presents with rapidly worsening respiratory function over days to weeks. AE account for about 1/2

  • 33 views
  • 25 Mar, 2022
  • 6 locations
Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a lung disease that limits the ability to breathe enough for a good workout. One way to improve the exercise training is to reduce the number of muscles

  • 0 views
  • 24 Mar, 2022
  • 1 location
A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

This study is being conducted to evaluate the safety and tolerability of single ascending and multiple ascending oral doses of NIP292 tablets administered following an overnight fast in healthy adult subjects.

Accepts healthy volunteers
  • 11 views
  • 21 Apr, 2022
  • 1 location